Pharma firm’s pre-tax profits up 37% to €66m as revenues top €600m

Pre-tax profits at the main Irish unit of pharmaceutical giant Servier increased 37% last year to €66.2m as revenues topped €600m.

Numbers employed at Servier (Ireland) Industries’ Arklow plant — which was subject to a fresh €47m investment four years ago — increased from 409 to 429 last year.

The principal activity of the French-owned group continues to be the manufacture of pharmaceutical products, primarily for the export market.